Enzyme proteins (i.e., basic synthetic chemicals) (except pharmaceutical use) manufacturing · North Carolina

Novozymes North America, Inc

Morrisville, NC · ~58 workers · 2 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
0.9
Avg TCR
3.3
Industry avg
0
Fatalities

The verdict

Novozymes North America, Inc runs at 27% of its industry's injury rate - far safer than the typical Enzyme proteins (i.e., basic synthetic chemicals) (except pharmaceutical use) manufacturing workplace, earning a grade A.

A
Excellent Safety Record
0.9
avg TCR · per 100 workers
3.3
industry benchmark (BLS)
0
recordable injuries tracked

Grade compares Novozymes North America, Inc's OSHA Total Case Rate of 0.9 to the Enzyme proteins (i.e., basic synthetic chemicals) (except pharmaceutical use) manufacturing BLS benchmark of 3.3 (27% of benchmark) across 2 years of Form 300A filings (2016–2024). <a href="/methodology">See methodology</a> for reporting-limitation caveats.

Injury rate over time

Novozymes North America, Inc's yearly Total Case Rate, against the 3.3 industry benchmark.

-101234 20232024 03.3 Industry benchmarkNovozymes North America, Inc TCR
Total Case Rate (recordable injuries per 100 full-time workers), OSHA ITA Form 300A. Industry benchmark: BLS IIF, NAICS 325199.

Where Novozymes North America, Inc falls in its industry

661 Enzyme proteins (i.e., basic s establishments

Safer than 56% of graded establishments in this industry, whose median TCR is 1.1.

More dangerous than peersSafer than peers

Narrower to North Carolina alone (the establishments it most directly competes with for workers and contracts): ranked #17 safest of 33 Enzyme proteins (i.e., basic s employers in North Carolina.

Trend analysis for Novozymes North America, Inc

Between 2023 and 2024, Novozymes North America, Inc's Total Case Rate improved from 1.8 to 0.0 recordable injuries per 100 full-time workers, a 100% decrease across 1 year of OSHA reporting.

The safest year on record was 2024, at a TCR of 0.0, while 2023 saw the highest rate, at 1.8, a spread of 1.8 points between the best and worst reporting years. That's a wide swing relative to the establishment's overall rate, worth checking the year-by-year table below for whether a single severe year is driving the average, rather than a sustained trend.

Summed across those 2 reporting years, Novozymes North America, Inc recorded 0 total injuries and illnesses, with no fatalities reported in any of those years. Readers comparing establishments should weigh the 2-year trend above alongside establishment size, since a larger workforce naturally accumulates more raw incidents even at a lower per-100-worker rate.

Verify This Employer with OSHA

The 0 injuries, 1 illnesses shown on this page for Novozymes North America, Inc are sourced from its own 2 years of mandatory OSHA Form 300A summaries. Cross-check the underlying establishment record directly against the federal source, name, NAICS classification, recordable case totals, and inspection history are all searchable on OSHA's Establishment-Specific Injury and Illness Data system.

Verify on OSHA Establishment Search

Source: U.S. Department of Labor, OSHA Establishment-Specific Injury and Illness Data. NAICS 325199 - Enzyme proteins (i.e., basic synthetic chemicals) (except pharmaceutical use) manufacturing.

DART Rate, Transparent Calculation (2024)

What is the DART rate formula?

DART (Days Away, Restricted, or Transferred) is computed by OSHA as incidents × 200,000 ÷ hours worked. The 200,000-hour denominator equals roughly 100 full-time workers, which lets establishments of very different sizes be compared directly.

0 DART incidents × 200,000 ÷ 110,200 hours worked = 0.00 DART

Methodology: 29 CFR 1904, OSHA Form 300A recordkeeping

Cross-Validating Context, Establishment vs Industry vs State

Benchmark TCR Source
Novozymes North America, Inc (this establishment) 0.88 OSHA ITA Form 300A, 2-year avg
Esters, not specified elsewhere by process, manufacturing industry avg 3.30 BLS IIF, NAICS 325199
North Carolina state avg (all industries) 3.89 OSHA ITA, state-level rollup

Industry benchmarks: Bureau of Labor Statistics, Injuries, Illnesses, and Fatalities (IIF) program

Reportable Incident Timeline

Year-by-year reportable incidents (recordable injuries + illnesses + fatalities) submitted by Novozymes North America, Inc to OSHA's Injury Tracking Application. Each row anchors to OSHA's inspection records search where you can pull the underlying inspection case numbers and citations for that establishment-year.

Source: OSHA Inspection Information System (IMIS) - inspection case-number records

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.0 0.0 0 0 0
2023 1.8 0.0 0 1 0

What this grade means for you

Use this grade as a relative read on Novozymes North America, Inc's reported OSHA injury record, strong versus its Enzyme proteins (i.e., basic synthetic chemicals) (except pharmaceutical use) manufacturing peers, but not a guarantee about any single site today.

  • At 27% of the Enzyme proteins (i.e., basic synthetic chemicals) (except pharmaceutical use) manufacturing benchmark, Novozymes North America, Inc reports fewer injuries than typical peers, still worth asking how safety is managed day to day. Know your rights
  • Judge this record against the wider Enzyme proteins (i.e., basic synthetic chemicals) (except pharmaceutical use) manufacturing sector, where injury rates vary widely, before comparing it in isolation. See the industry
  • Grades reflect 2016–2024 filings; check the latest establishment record straight from OSHA, or look up a different employer. Look up another

Safety grades reflect employers' self-reported OSHA Form 300A filings from 2016 to 2024 and can lag current conditions. A grade is not a guarantee that any specific workplace is safe or unsafe today. See our methodology and disclaimer.

Frequently Asked Questions

What is Novozymes North America, Inc's safety grade?
Novozymes North America, Inc has a safety grade of A (Excellent Safety Record). This grade is based on their average Total Case Rate (TCR) of 0.9 compared to the BLS industry benchmark of 3.3 for Enzyme proteins (i.e., basic synthetic chemicals) (except pharmaceutical use) manufacturing.
How many injuries has Novozymes North America, Inc reported?
Novozymes North America, Inc has reported 0 total injuries and 0 fatalities across 2 years of OSHA data (2024, 2023). This data comes from mandatory OSHA Injury Tracking Application (ITA) reports.

Similar Employers

Matched by safety record across the industry, by workforce size within North Carolina, and by nearby establishments in Morrisville - a different peer set than the category browse links below.

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainSafetyScore Editorial

Every figure and grade on PlainSafetyScore is computed directly from OSHA's published Injury Tracking Application data and BLS industry benchmarks, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these safety grades, or report a data error. Data current as of 2016-2024 OSHA ITA release.